Carmen Jeffrey Del
Chief Commercial Officer, Catalyst Pharmaceuticals.
Companies
- Catalyst PharmaceuticalsChief Commercial Officer Jul 2, 2020 to now1
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
Catalyst Pharmaceuticals CPRX0 shares2Jul 15, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Jul 15, 2026Returned to company 14,337 shares at $31.50 of Catalyst Pharmaceuticals2
- Dec 29, 2025Shares withheld for tax 3,839 shares of Catalyst Pharmaceuticals3
- Dec 29, 2025Exercised options 8,667 shares of Catalyst Pharmaceuticals3
- Dec 8, 2025Shares withheld for tax 2,492 shares of Catalyst Pharmaceuticals4
- Dec 8, 2025Exercised options 8,039 shares of Catalyst Pharmaceuticals4
- Nov 26, 2025Sold 10,983 shares at $23.33 of Catalyst Pharmaceuticals5
- Nov 26, 2025Exercised options 10,983 shares at $4.21 of Catalyst Pharmaceuticals5
- Nov 21, 2025Shares withheld for tax 1,641 shares of Catalyst Pharmaceuticals6
- Nov 21, 2025Exercised options 5,603 shares of Catalyst Pharmaceuticals6
- Mar 3, 2025Sold 30,423 shares at $22.89 of Catalyst Pharmaceuticals7
- Feb 14, 2025Shares withheld for tax 3,125 shares of Catalyst Pharmaceuticals8
- Feb 14, 2025Exercised options 10,667 shares of Catalyst Pharmaceuticals8
- Dec 27, 2024Shares withheld for tax 3,839 shares of Catalyst Pharmaceuticals9
- Dec 27, 2024Exercised options 8,667 shares of Catalyst Pharmaceuticals9
- Dec 9, 2024Shares withheld for tax 2,355 shares of Catalyst Pharmaceuticals10
- Dec 9, 2024Exercised options 8,039 shares of Catalyst Pharmaceuticals10
- Aug 9, 2024Sold 30,000 shares at $18.42 of Catalyst Pharmaceuticals11
- Aug 9, 2024Exercised options 30,000 shares at $2.86 of Catalyst Pharmaceuticals11
- Aug 9, 2024Sold 6,058 shares at $18.44 of Catalyst Pharmaceuticals11
- Jun 7, 2024Sold 7,541 shares at $16.07 of Catalyst Pharmaceuticals12
- Feb 15, 2024Shares withheld for tax 3,125 shares of Catalyst Pharmaceuticals13
- Feb 15, 2024Exercised options 10,667 shares of Catalyst Pharmaceuticals13
- Dec 27, 2023Shares withheld for tax 3,839 shares of Catalyst Pharmaceuticals14
- Dec 27, 2023Exercised options 8,666 shares of Catalyst Pharmaceuticals14
- Jun 27, 2023Shares withheld for tax 3,942 shares of Catalyst Pharmaceuticals15
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3SEC EDGARForm 4 filed Dec 30, 2025
- 4SEC EDGARForm 4 filed Dec 10, 2025
- 5SEC EDGARForm 4 filed Nov 28, 2025
- 6SEC EDGARForm 4 filed Nov 24, 2025
- 7SEC EDGARForm 4 filed Mar 5, 2025
- 8SEC EDGARForm 4 filed Feb 19, 2025
- 9SEC EDGARForm 4 filed Dec 31, 2024
- 10SEC EDGARForm 4 filed Dec 11, 2024
- 11SEC EDGARForm 4 filed Aug 13, 2024
- 12SEC EDGARForm 4 filed Jun 11, 2024
- 13SEC EDGARForm 4 filed Feb 16, 2024
- 14SEC EDGARForm 4 filed Dec 29, 2023
- 15SEC EDGARForm 4 filed Jun 29, 2023